default author photo

Shigeru Suga

Mie National Hospital

SCHOLARLY PAPERS

3

DOWNLOADS

215

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Global Impact of 10- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project

Number of pages: 36 Posted: 19 Mar 2024
Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Department of International Health, International Vaccine Access Center, University of Oxford - KEMRI-Coast Centre for Geographical Medicine and Research, Emory University - Rollins School of Public Health, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, University of Massachusetts Worcester - UMass Chan Medical School, Johns Hopkins University - Bloomberg School of Public Health, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, Yale University - Institute for Global Health, OsloMet - Oslo Metropolitan University - Faculty of Health Sciences, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, Santé Publique France, RWTH Aachen University - RWTH University Hospital Aachen, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, Mie National Hospital, National Institute for Public Health and Environment, National Medicines Institute, National Institute of Public Health, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, Rey Juan Carlos University, University of Melbourne - Murdoch Children's Research Institute, University of Calgary, Institute of Public Health of Chile - National Agency for Medical Devices, Innovation and Development (ANDID), Tampere University - Faculty of Social Sciences, Health Protection Surveillance Centre (HPSC), Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, Government of the United Kingdom - Public Health Scotland, Public Health Agency of Sweden, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, The University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Child Health Research Foundation, Johns Hopkins University - Department of International Health, International Vaccine Access Center, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), National Institute of Public Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Public Health Organization, Athens, affiliation not provided to SSRN, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Ben-Gurion University of the Negev - Faculty of Health Science, European Centre for Disease Prevention and Control, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Generalitat de Catalunya, Ministry of Health, Oman, Kenya Medical Research Institute (KEMRI), Italian National Institute of Health, Government of the United States of America - National Center for Emerging and Zoonotic Infectious Diseases, Instituto Adolfo Lutz, Kenya Medical Research Institute (KEMRI), University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Johns Hopkins University - Department of International Health, International Vaccine Access Center, Johns Hopkins University - International Vaccine Access Center and Independent
Downloads 130 (558,171)
Citation 3

Abstract:

Loading...

invasive pneumococcal disease, pneumococcal conjugate vaccines, serotypes, vaccine impact, incidence, serotype replacement, indirect protection

2.

Nationwide Population-Based Surveillance of Invasive Pneumococcal Disease in Children in Japan (2014–2022): Impact of 13-Valent Pneumococcal Conjugate Vaccine and Covid-19 Pandemic

Number of pages: 40 Posted: 02 Jan 2025
affiliation not provided to SSRN, National Institute of Infectious Diseases, affiliation not provided to SSRN, Okinawa Prefectural Nanbu Medical enter & Children’s Medical Center - Department of Pediatric Infectious Diseases, Toyama Institute of Health - Department of Research Planning, affiliation not provided to SSRN, Kochi University, Okayama University, Niigata University, Fukushima Regional Center for the Japan Environmental and Children’s Study, Hokkaido University, Chiba University - Chiba University Hospital, Chiba University - Chiba University Hospital and Mie National Hospital
Downloads 85 (771,553)

Abstract:

Loading...

Invasive pneumococcal disease, serotype replacement, Japanese children, COVID-19, pneumococcal conjugate vaccine, population-based surveillance

3.

Introduction of Cytomegalovirus Immunoglobulin M Antibody Titer Testing into a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women

Posted: 23 Jul 2022
Mie University - Department of Obstetrics and Gynecology, Mie University - Department of Obstetrics and Gynecology, Mie University - Department of Obstetrics and Gynecology, Kurashiki Central Hospital, Mie University - University Hospital, Aisenkai Nichinan Hospital, Mie National Hospital, Mie University - Department of Obstetrics and Gynecology, Mie Association of Obstetricians and Gynecologists, Mie Association of Obstetricians and Gynecologists and Mie University - Department of Obstetrics and Gynecology

Abstract:

Loading...

cytomegalovirus, IgM antibody, serological screening, maternal antibody screening, congenital infection